Transfusion requirements after bone marrow transplantation from HLA-identical siblings: Effects of donor-recipient ABO incompatibility

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 151-156

  Mehta, J ^a   Powles, R ^a   Singhal, S ^a   Horton, C ^a   Hamblin, M ^a   Zomas, A ^a   Saso, R ^a   Treleaven, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Allogeneic bone marrow transplantation; Blood group; Leukemia; Platelets; Red cells; Transfusions

Indexed keywords

CYCLOPHOSPHAMIDE; MELPHALAN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HLA SYSTEM; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

EID: 0029781973     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wulff JC, Santner TJ, Storb R et al. Transfusion requirements after HLA-identical marrow transplantation in 82 patients with aplastic anemia. Vox Sang 1983; 44: 366-374.
2. Osterwalder B, Gratwohl A, Reusser P et al. Hematological support in patients undergoing allogenetic bone marrow transplantation. Recent Results Cancer Res 1988; 108: 44-52.
3. Bensinger W, Petersen FB, Banaji M et al. Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission. Bone Marrow Transplant 1989; 4: 409-414.
4. Pihlstedt P, Paulin T, Sundberg B et al. Blood transfusion in marrow graft recipients. Ann Hematol 1992; 65: 66-70.
5. Helenglass G, Powles RL, McElwain TJ et al. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Bone Marrow Transplant 1988; 3: 21-29.
6. Mehta J, Powles RL, Treleaven J, Milan S. Busulfan-melphalan conditioning prior to bone marrow transplantation for poor-risk leukemia. Eur J Cancer 1993; 29A (Suppl. 6): S152.
7. Mehta J, Powles RL, Mitchell P et al. Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning. Bone Marrow Transplant 1994; 13: 583-587.
8. Mehta J, Powles R, Treleaven J et al. Melphalan versus cyclophosphamide with total body irradiation as conditioning for allogeneic bone marrow transplantation in first remission acute myeloid leukemia. Blood 1994; 84 (Suppl. 1): 714a.
9. Powles RL, Morgenstern GR, Kay HE et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1983; 1: 612-615.
10. Mehta J, Powles R, Horton C et al. The relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 1995; 15: 853-858.
11. Sniecinski IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45: 530-534.
12. Gmur JP, Burger J, Schaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290-295.
13. Hows J, Beddow K, Gordon-Smith E et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986; 67: 177-181.
14. Klumpp TR. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991; 8: 159-170.